Literature DB >> 3145778

A profile of vigabatrin.

J P Mumford.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3145778

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN： 0262-8767


× No keyword cloud information.
  4 in total

Review 1.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 2.  A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.

Authors:  J Srinivasan; A Richens
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 3.  Vigabatrin. Clinical pharmacokinetics.

Authors:  E Rey; G Pons; G Olive
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.

Authors:  R D Elwes; C D Binnie
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.